Jin Medical International Ltd.

NasdaqCM:ZJYL Stock Report

Market Cap: US$139.3m

Jin Medical International Balance Sheet Health

Financial Health criteria checks 4/6

Jin Medical International has a total shareholder equity of $28.6M and total debt of $11.3M, which brings its debt-to-equity ratio to 39.7%. Its total assets and total liabilities are $45.8M and $17.2M respectively. Jin Medical International's EBIT is $3.6M making its interest coverage ratio -7.8. It has cash and short-term investments of $26.8M.

Key information

39.7%

Debt to equity ratio

US$11.32m

Debt

Interest coverage ratio-7.8x
CashUS$26.76m
EquityUS$28.55m
Total liabilitiesUS$17.25m
Total assetsUS$45.80m

Recent financial health updates

Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Aug 24
Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Recent updates

Why Investors Shouldn't Be Surprised By Jin Medical International Ltd.'s (NASDAQ:ZJYL) 31% Share Price Surge

Jan 15
Why Investors Shouldn't Be Surprised By Jin Medical International Ltd.'s (NASDAQ:ZJYL) 31% Share Price Surge

Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 30
Jin Medical International Ltd.'s (NASDAQ:ZJYL) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Sep 07
Some Confidence Is Lacking In Jin Medical International Ltd. (NASDAQ:ZJYL) As Shares Slide 31%

Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Aug 24
Jin Medical International (NASDAQ:ZJYL) Seems To Use Debt Quite Sensibly

Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Jul 24
Revenues Not Telling The Story For Jin Medical International Ltd. (NASDAQ:ZJYL) After Shares Rise 25%

Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jul 17
Capital Allocation Trends At Jin Medical International (NASDAQ:ZJYL) Aren't Ideal

Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jun 04
Jin Medical International Ltd. (NASDAQ:ZJYL) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely

Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

Dec 27
Jin Medical International Ltd.'s (NASDAQ:ZJYL) Shares Climb 372% But Its Business Is Yet to Catch Up

What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

Sep 29
What Jin Medical International Ltd.'s (NASDAQ:ZJYL) 69% Share Price Gain Is Not Telling You

Financial Position Analysis

Short Term Liabilities: ZJYL's short term assets ($42.8M) exceed its short term liabilities ($17.2M).

Long Term Liabilities: ZJYL's short term assets ($42.8M) exceed its long term liabilities ($96.2K).


Debt to Equity History and Analysis

Debt Level: ZJYL has more cash than its total debt.

Reducing Debt: ZJYL's debt to equity ratio has increased from 26.8% to 39.7% over the past 5 years.

Debt Coverage: ZJYL's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: ZJYL earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 00:15
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jin Medical International Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution